Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc.（SION）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · SION · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
153
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Sionna Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
SION 季度内部人买卖趋势
SION 内幕交易卖出 · SION 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · SION CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SION 高管卖出股份 · SION 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 27, 2026 | Thompson Peter A. Director | Sale | 101 | $4K | Form 4 |
| May 27, 2026 | ORBIMED ADVISORS LLC Director | Sale | 101 | $4K | Form 4 |
| May 7, 2026 | Thompson Peter A. Director | Sale | 48,546 | $2.17M⚡ | Form 4 |
| May 8, 2026 | Thompson Peter A. Director | Sale | 59,767 | $2.66M⚡ | Form 4 |
| May 11, 2026 | Thompson Peter A. Director | Sale | 184,639 | $8.53M⚡ | Form 4 |
| May 7, 2026 | ORBIMED ADVISORS LLC Director | Sale | 48,546 | $2.17M⚡ | Form 4 |
| May 8, 2026 | ORBIMED ADVISORS LLC Director | Sale | 59,767 | $2.66M⚡ | Form 4 |
| May 11, 2026 | ORBIMED ADVISORS LLC Director | Sale | 184,639 | $8.53M⚡ | Form 4 |
| Apr 17, 2026 | Thompson Peter A. Director | Sale | 52,397 | $2.34M⚡ | Form 4 |
| Apr 18, 2026 | Thompson Peter A. Director | Sale | 2,948 | $131K | Form 4 |
| Apr 17, 2026 | ORBIMED ADVISORS LLC Director | Sale | 52,397 | $2.34M⚡ | Form 4 |
| Apr 18, 2026 | ORBIMED ADVISORS LLC Director | Sale | 2,948 | $131K | Form 4 |
| Apr 14, 2026 | Thompson Peter A. Director | Sale | 47,814 | $2.13M⚡ | Form 4 |
| Apr 15, 2026 | Thompson Peter A. Director | Sale | 235,863 | $10.53M⚡ | Form 4 |
| Apr 16, 2026 | Thompson Peter A. Director | Sale | 226,906 | $10.29M⚡ | Form 4 |
| Apr 14, 2026 | ORBIMED ADVISORS LLC Director | Sale | 47,814 | $2.13M⚡ | Form 4 |
| Apr 15, 2026 | ORBIMED ADVISORS LLC Director | Sale | 235,863 | $10.53M⚡ | Form 4 |
| Apr 16, 2026 | ORBIMED ADVISORS LLC Director | Sale | 226,906 | $10.29M⚡ | Form 4 |
| Mar 5, 2026 | Fitzpatrick Jennifer Chief Legal Officer | Option | 10,250 | $63K | Form 4 |
| Mar 5, 2026 | Fitzpatrick Jennifer Chief Legal Officer | Sale | 10,250 | $347K | Form 4 |
| Feb 2, 2026 | Thompson Peter A. Director | Sale | 1,890 | $84K | Form 4 |
| Feb 3, 2026 | Thompson Peter A. Director | Sale | 29,063 | $1.30M⚡ | Form 4 |
| Feb 2, 2026 | ORBIMED ADVISORS LLC Director | Sale | 1,890 | $84K | Form 4 |
| Feb 3, 2026 | ORBIMED ADVISORS LLC Director | Sale | 29,063 | $1.30M⚡ | Form 4 |
| Jan 22, 2026 | TPG GP A, LLC 10 percent owner | Sale | 250,000 | $10.00M⚡ | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SION 内幕交易
SION 内幕交易
Sionna Therapeutics, Inc.（SION）内幕交易数据来源于公司内部人（包括RA CAPITAL MANAGEMENT, L.P. (Director), Thompson Peter A. (Director), ORBIMED ADVISORS LLC (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。SION内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Sionna Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
SION 内幕交易 · 5个问题Sionna Therapeutics, Inc.（SION）的内部人包括高管和董事，如RA CAPITAL MANAGEMENT, L.P. (Director), Thompson Peter A. (Director), ORBIMED ADVISORS LLC (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026